134 related articles for article (PubMed ID: 20201692)
41. Evaluation of a fully automated end-tidal carbon monoxide instrument for breath analysis.
Vreman HJ; Baxter LM; Stone RT; Stevenson DK
Clin Chem; 1996 Jan; 42(1):50-6. PubMed ID: 8565232
[TBL] [Abstract][Full Text] [Related]
42. Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Bhatia A; Chua MC; Dela Puerta R; Rajadurai VS
Neonatology; 2020; 117(5):612-618. PubMed ID: 32894848
[TBL] [Abstract][Full Text] [Related]
43. Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis.
Christensen RD; Malleske DT; Lambert DK; Baer VL; Prchal JT; Denson LE; Gerday E; Weaver Lewis KA; Shepherd JG
Neonatology; 2016; 109(1):1-5. PubMed ID: 26394287
[TBL] [Abstract][Full Text] [Related]
44. Transfusing children with hemoglobinopathies.
Allali S; Taylor M; Albinni S; Amiranoff D; de Montalembert M
Transfus Clin Biol; 2019 Sep; 26(3):147-149. PubMed ID: 31300265
[TBL] [Abstract][Full Text] [Related]
45. Improvement Initiative: End-Tidal Carbon Monoxide Measurement in Newborns Receiving Phototherapy.
Bahr TM; Shakib JH; Stipelman CH; Kawamoto K; Lauer S; Christensen RD
J Pediatr; 2021 Nov; 238():168-173.e2. PubMed ID: 34260896
[TBL] [Abstract][Full Text] [Related]
46. [Erythrocyte transfusions in hemoglobinopathies: indications].
Galacteros F
Transfus Clin Biol; 1994; 1(1):15-7. PubMed ID: 8186847
[No Abstract] [Full Text] [Related]
47. Craniofacial deformities in transfusion-dependent thalassemia patients in Malaysia: prevalence and effect of treatment.
Toman HA; Hassan R; Hassan R; Nasir A
Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1233-40. PubMed ID: 22299450
[TBL] [Abstract][Full Text] [Related]
48. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists Number 64, July 2005 (Replaces Committee Opinion Number 238, July 2000): hemoglobinpathies in pregnancy.
ACOG Committee
Obstet Gynecol; 2005 Jul; 106(1):203-10. PubMed ID: 15994657
[TBL] [Abstract][Full Text] [Related]
49. Mid-infrared laser spectroscopy for online analysis of exhaled CO.
Sowa M; Mürtz M; Hering P
J Breath Res; 2010 Dec; 4(4):047101. PubMed ID: 21383488
[TBL] [Abstract][Full Text] [Related]
50. Positive effects of ultrasound-guided peripheral IV insertion on pediatric sickle cell anemia/thalassemia patients receiving automated red cell exchange procedures or chronic transfusion therapy.
Mahon P; Grouchy K; McCartney H; Douglas K; Wu JK
J Clin Apher; 2021 Feb; 36(1):143-148. PubMed ID: 33247605
[TBL] [Abstract][Full Text] [Related]
51. [Transfusion in patients with hemoglobinopathies].
de Montalembert M
Transfus Clin Biol; 2000 Dec; 7(6):553-8. PubMed ID: 11204841
[TBL] [Abstract][Full Text] [Related]
52. [Anti-erythrocyte and anti-HLA immunization in hemoglobinopathies].
Ben Salah N; El Borgi W; Ben Lakhal F; Ben Mansour M; Gouider E; Gorgi Y; Bardi R; Zoueri B; Hafsia R
Transfus Clin Biol; 2014 Dec; 21(6):314-9. PubMed ID: 25458987
[TBL] [Abstract][Full Text] [Related]
53. Disturbed heart rate variability: a dose-dependent response to elevated nitric oxide and carbon monoxide in exhaled breath.
Qiu G; Feng Y; Li X; Deng H; Dai X; Deng Q; Huang S; He M; Guo H; Zhang X; Hu FB; Wu T
Int J Cardiol; 2013 Oct; 168(6):e155-7. PubMed ID: 24041983
[No Abstract] [Full Text] [Related]
54. New updating into hemoglobinopathies.
Fucharoen S; Winichagoon P
Int J Lab Hematol; 2012 Dec; 34(6):559-65. PubMed ID: 22762348
[TBL] [Abstract][Full Text] [Related]
55. Higher ETCOc predicts longer phototherapy treatment in neonatal hyperbilirubinemia.
Zhan YL; Peng HB; Jin ZC; Su JF; Tan XY; Zhao L; Zhang L
Front Pediatr; 2023; 11():1154350. PubMed ID: 37114002
[TBL] [Abstract][Full Text] [Related]
56. End-tidal carbon monoxide and hemolysis.
Tidmarsh GF; Wong RJ; Stevenson DK
J Perinatol; 2014 Aug; 34(8):577-81. PubMed ID: 24743136
[TBL] [Abstract][Full Text] [Related]
57. Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia.
Elsaie AL; Taleb M; Nicosia A; Zangaladze A; Pease ME; Newton K; Schutzman DL
J Perinatol; 2020 Oct; 40(10):1513-1517. PubMed ID: 32203175
[TBL] [Abstract][Full Text] [Related]
58. Hematologic Conditions: Common Hemoglobinopathies.
Keber B; Lam L; Mumford J; Flanagan B
FP Essent; 2019 Oct; 485():24-31. PubMed ID: 31613565
[TBL] [Abstract][Full Text] [Related]
59. Exhaled carbon monoxide concentration: a reliable predictor of smoking status?
Schober P; Schwarte LA; Loer SA
Eur J Anaesthesiol; 2011 Feb; 28(2):146-7. PubMed ID: 21157357
[No Abstract] [Full Text] [Related]
60. Exhaled carbon monoxide concentration is not elevated in patients with inflammatory bowel disease.
Nitta H; Kinoyama M; Teramoto F; Watanabe A; Koga H; Haruma K; Akagi R; Ueda H
Clin Exp Med; 2007 Jun; 7(2):77-81. PubMed ID: 17609880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]